Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1,994 DKK | +63.85% | +4.14% | +14.24% |
Apr. 30 | Pfizer, Genmab Say FDA Approves Tivak to Treat Cervical Cancer | MT |
Apr. 30 | Genmab, Pfizer Win US FDA Approval for Cervical Cancer Treatment | MT |
- Stock Market
- Equities
- GMAB Stock
- Stock
- News Genmab
- Transcripts